SCHEMBL13699049

SCHEMBL13699049

COC(=O)c1ccc2c(ccn2CCl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 2/20 0.55
HPGD P15428 2/20 0.55
POLB P06746 1/20 0.55
APOBEC3A P31941 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HSD17B10 Q99714 1/20 0.55
APOBEC3G Q9HC16 1/20 0.55
HDAC6 Q9UBN7 10/20 0.54
HDAC8 Q9BY41 8/20 0.54
HDAC11 Q96DB2 2/20 0.54
HDAC3 O15379 8/20 0.50
HDAC1 Q13547 8/20 0.50
HDAC2 Q92769 8/20 0.50
HDAC10 Q969S8 5/20 0.50
TUBB4A P04350 2/20 0.49
TUBB P07437 2/20 0.49
TUBA3C P0DPH7 2/20 0.49
TUBA1B P68363 2/20 0.49
TUBA4A P68366 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2324058 0.88 TUBB4A (0.62) KDM4EALDH1A1HPGDPOLBAPOBEC3A
SCHEMBL15971349 0.87 KDM4E (0.55) KDM4EALDH1A1HPGDPOLBAPOBEC3A
SCHEMBL3144113 0.87 KDM4E (0.51) KDM4EALDH1A1HPGDPOLBAPOBEC3A
SCHEMBL14527151 0.85 HTR2C (0.63) KDM4EALDH1A1HPGDPOLBAPOBEC3A
SCHEMBL3109875 0.85 HDAC6 (0.61) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL1809488 0.84 HDAC6 (0.51) KDM4EALDH1A1HPGDPOLBAPOBEC3A
SCHEMBL27945690 0.84 KDM4E (0.49) KDM4EALDH1A1HPGDPOLBAPOBEC3A
SCHEMBL6086357 0.84 HDAC6 (0.65) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL30185511 0.84 HDAC6 (0.67) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL30185500 0.84 HDAC6 (0.78) HDAC6HDAC8HDAC11HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R KDM4E 1604/4885ALDH1A1 4542/4885HPGD 1474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.